Pay in 4 interest-free payments of $7.20 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
SURMOUNT-5: The head-to-head trial Published in the New England Journal of Medicine in 2025, SURMOUNT-5 was the first randomised trial to directly compare tirzepatide (Mounjaro) with semaglutide (Wegovy) at equivalent maximum doses in adults with obesity without type 2 diabetes
Pricing is transparent, with no hidden fees
We offer a variation of prescribed medication (all FDA approved) that is appropriate for your specific needs as well as pharmaceutical grade supplements
This is the most significant safety concern
As documented by the FDA, practices such as taking a higher amount of the drug in a single dose, taking doses more frequently, or increasing the amount of the drug more quickly can cause serious gastrointestinal problems, including nausea, vomiting, diarrhea, and abdominal pain
These structural characteristics collectively distinguish Retatrutide from unmodified peptide sequences and support its classification within metabolic and appetitesignaling research categories
US$ 27.32
US$ 23.14
US$ 27.74
US$ 22.13
US$ 27.77
